*Corresponding author:
Massimiliano Manfrin, Department of Cardiology, San Maurizio Regional Hospital, Bolzano, ItalyReceived: March 15, 2018; Published: April 04, 2018
DOI: 10.26717/BJSTR.2018.03.000911
To view the Full Article Peer-reviewed Article PDF
Purpose: to evaluate the anti-arrhythmic effect of statins in patients receiving an implantable cardioverter-defibrillator (ICD) for ventricular tachycardia/ventricular fibrillation (VT/VF).
Methods: 85 patients with ischemic dilated cardiomyopathy undergoing ICD implantation for sudden cardiac death (SCD) prevention (primary prevention) were enrolled in the study. 63 patients (72%) were on treatment with statins (group 1), and 22 were not (group 2). The following end points were analyzed: recurrences of ventricular arrhythmias (VA) requiring ICD intervention and mortality.
Results: after a median follow up of 46.2 months (interquartile range 26.9 - 72.8 months) 28 patients (32.9%) had at least one VA which required ICD intervention. Multivariate analysis showed that treatment with statins was the only independent predictor of arrhythmic events reduction (events requiring ICD intervention) (p=0.042). Under the 63 patients of group 1, 17 (27%) had appropriate ICD intervention, while under the 22 patients of group 2, 11 (50%) had appropriate ICD intervention (p=0.0185). The mortality in group 1 was 28.6% (18 patients), while in group 2 was 50% (11 patients) (p=0.0284).
Conclusion: the use of statins in patients with ischemic dilated cardiomyopathy undergoing ICD implantation was associated with a reduction in the risk of death and VT/VF episodes requiring ICD intervention. These findings suggest that statins may have anti-arrhythmic properties. These findings should be confirmed in a prospective, randomized clinical trial.
Abbreviations: ICD: Implantable Cardioverter-Defibrillator; SCD: Sudden Cardiac Death; CAD: Coronary Artery Disease; SCD: Sudden Cardiac Deaths; HR: Heart Rate; FVT: Fast Ventricular Tachycardia; VF: Ventricular Fibrillation
Abstract| Introduction| Methods| Results| Discussion| Study limitations| References|
International Association of Landscape Archaeology, Czech Glass Society, Czech Republic
Department of Chemistry, Semenov Institute of Chemical Physics, USSR Academy of Sciences, Moscow, Russia
Pharmaco-kinetics, dynamics and Drug Metabolism, Touro College of Pharmacy, USA
Professor of Nuclear Medicine, Faculty of Medicine and Surgery, University of Milan, Milan, Italy
Associate Professor at Department of Breast and Thyorid Surgey, Chongqing General Hospital, China